Surgery in patients with vascular malformations of the head and neck: Value of coagulation disorders

Phlebology

Volumn 24, Issue 1, 2009, Pages 38-42

  Wiegand, S ^a   Eivazi, B ^a   Karger, R ^a   Al Kadah, B ^a   Sesterhenn, A M ^a   Werner, J A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Coagulation disorder; PFA 100; Vascular malformation

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; BLOOD CLOTTING FACTOR; D DIMER; FIBRINOGEN; PROTHROMBIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CHILD; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; FEMALE; HEMOSTASIS; HUMAN; LYMPHATIC SYSTEM DISEASE; MALE; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; VEIN MALFORMATION; VON WILLEBRAND DISEASE; BLOOD CLOTTING TEST; HEAD; HEMANGIOMA; MIDDLE AGED; NECK; POSTOPERATIVE COMPLICATION; RISK FACTOR; VASCULAR TUMOR; VASCULARIZATION;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CHILD; FEMALE; HEAD; HEMANGIOMA; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NECK; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; VASCULAR MALFORMATIONS; VASCULAR NEOPLASMS; YOUNG ADULT;

EID: 63149162330     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2008.008019     Document Type: Article

References (23)

1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-422 (Pubitemid 12191292)
2. Belov S. Classification of congenital vascular defects. Int Angiol 1990;9:141-146
3. Lee BB, Laredo J, Lee TS, Huh S, Neville R. Terminology and classification of congenital vascular malformations. Phlebology 2007;22:249-252
4. Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 1998;102:643-654 (Pubitemid 28402605)
5. Jeong HS, Baek CH, Son YI, Kim TW, Lee BB, Byun HS. Treatment of extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol 2006;126:295-300 (Pubitemid 43259235)
6. Werner JA, Dünne AA, Folz BJ, et al. Current concepts in the classification, diagnosis and treatment of hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol 2001;258:141-149 (Pubitemid 32260933)
7. Zio O, Ragni MV. Bleeding manifestations in males with von Willebrand disease. Haemophilia 2004;10:162-168 (Pubitemid 38312643)
8. Böck M, De Haan J, Beck KH, et al. Standardization of the PFA-100 platelet function testing 105 mmol/l buffered citrate: effect of gender, smoking and oral contraceptives. Br J Haematol 1999;106:898 (Pubitemid 29463001)
9. Werner JA, Eivazi B, Folz BJ, Dünne AA. State of the art of classification, diagnostics and therapy for cervicofacial hemangiomas and vascular malformations. Laryngorhinootologie 2006;85:883-889 (Pubitemid 46031214)
10. Lee BB, Laredo J, Kim YW, Neville R. Congenital vascular malformations: general treatment principles. Phlebology 2007;22:258-263
11. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005;130:3-10 (Pubitemid 40979127)
12. Hambleton J. Diagnosis and incidence of inherited von Willebrand disease. Curr Opin Hematol 2001;8:306-311 (Pubitemid 32826501)
13. Federici AB. Diagnosis of von Willebrand disease. Haemophilia 1998;4:654-660 (Pubitemid 28351901)
14. Kundu SK, Heilmann EJ, Sio R, Garcia C, Ostgaard RA. Characterization of an in vitro platelet function analyzer- PFA-100. Clin Appl Thromb Hemost 1996;2:241-249 (Pubitemid 126699612)
15. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202 (Pubitemid 28180831)
16. Wuillemin WA, Gasser KM, Zeerleder SS, Lämmle B. Evaluation of a platelet function analyser (PFA-100) in patients with a bleeding tendency. Swiss Med Wkly 2002;132:443-448 (Pubitemid 35396602)
17. Buchanan MR, Hirsh J. Effect of aspirin on hemostasis and thrombosis. N Engl Reg Allergy Proc 1986;7:6
18. El-Dessouky M, Azmy AF, Raine PA, Young DG, Kasabach- Merritt syndrome. J Pediatr Surg 1988;23:109-111
19. North PE, Kahn T, Cordisco MR, Dadras SS, Detmar M, Frieden IJ. Multifocal lymphangioendotheliomatosis with thrombocytopenia. Arch Dermatol 2004;140:599-606
20. Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42:225-235 (Pubitemid 30469619)
21. Sarkar M, Mulliken JB, Kozakewich HP, Robertson RI, Borrows PE. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100:1377-1386 (Pubitemid 27508197)
22. Richards DS, Lutfi E, Mullins D, Sandler DL, Raynor D. Prenatal diagnosis of fetal disseminated intravascular coagulation associated with umbical cord arteriovenous malformation. J Ultrasound Med 1988;5:211-213
23. Karger R, Donner-Banzhoff N, Müller H-H, Kretschmer V, Hunink M. Diagnostic performance of the platelet function analyzer (PFA-100w) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systematic review and meta-analysis. Platelets 2007;18:249-260 (Pubitemid 46854816)